117 related articles for article (PubMed ID: 3949446)
1. S.E.M. study II: Protective effect of ranitidine against gastric and duodenal lesions induced by non-steroidal anti-inflammatory drugs.
Zoli G; Pasquinelli G; Bonvicini F; Gasbarrini G; Laschi R
Int J Tissue React; 1986; 8(1):71-7. PubMed ID: 3949446
[TBL] [Abstract][Full Text] [Related]
2. S.E.M. study I: Gastric and duodenal lesions induced by non-steroidal anti-inflammatory drugs (aspirin, piroxicam) in man.
Zoli G; Pasquinelli G; Bonvicini F; Gasbarrini G; Laschi R
Int J Tissue React; 1986; 8(1):47-53. PubMed ID: 3949442
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of the safety and efficacy of ebrotidine versus ranitidine and placebo in the prevention of piroxicam-induced gastroduodenal lesions.
Puscas I; Puscas C; Coltau M; Pasca R; Torres J; Márquez M; Herrero E; Fillat O; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):568-72. PubMed ID: 9205767
[TBL] [Abstract][Full Text] [Related]
4. [Ranitidine in the treatment of non-steroidal anti-inflammatory agent-induced damage of the stomach and duodenal mucosa. Results of a randomized, placebo-controlled double-blind study in patients with rheumatic diseases].
Simon B; Beckers KH; Biewer W; Bouzo MH; Dammann HG; Gebest HJ; Müller P; Schütz E
Z Gastroenterol; 1988 Jun; 26(6):310-3. PubMed ID: 3061183
[TBL] [Abstract][Full Text] [Related]
5. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
Bianchi Porro G; Lazzaroni M; Petrillo M
Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319
[TBL] [Abstract][Full Text] [Related]
6. [A single evening dose of 300 mg ranitidine in the treatment of acute attacks of gastric and duodenal ulcers. Evaluation of 1,208 patients].
Bories P; Tournade JM; Alberola B; Pappo M
Ann Gastroenterol Hepatol (Paris); 1988 Oct; 24(5):227-32. PubMed ID: 3061358
[TBL] [Abstract][Full Text] [Related]
7. Variations in the risk of gastrointestinal hemorrhage with non-steroidal anti-inflammatory drugs and localization of lesions.
Pulanić R; Dubravcić D; Ostojić-Pulanić B; Vrhovac B
Acta Med Croatica; 1998; 52(2):91-8. PubMed ID: 9682495
[TBL] [Abstract][Full Text] [Related]
8. Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine.
Ehsanullah RS; Page MC; Tildesley G; Wood JR
BMJ; 1988 Oct; 297(6655):1017-21. PubMed ID: 3142593
[TBL] [Abstract][Full Text] [Related]
9. Ranitidine in the treatment of peptic ulcer.
Makalinao AU; Zaño FM
Clin Ther; 1984; 6(2):185-92. PubMed ID: 6322992
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of colloid bismuth subcitrate (De-Nol) in gastropathies induced by nonsteroid anti-inflammatory drugs: an open controlled 4-week trial].
Karateev AE; Nasonov EL; Radenska-Lopovok SG
Ter Arkh; 2005; 77(2):46-9. PubMed ID: 15807452
[TBL] [Abstract][Full Text] [Related]
11. Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter study.
Raskin JB; White RH; Jaszewski R; Korsten MA; Schubert TT; Fort JG
Am J Gastroenterol; 1996 Feb; 91(2):223-7. PubMed ID: 8607484
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of non-steroidal anti-inflammatory drug-induced damage to gastric mucosa using ranitidine. Comparison of the effectiveness of 2 dosages].
Müller P; Dammann HG; Marinis E; Weise D; Simon B
Fortschr Med; 1989 Oct; 107(31):667-70. PubMed ID: 2687142
[TBL] [Abstract][Full Text] [Related]
13. Effect of anti-inflammatory drug administration in patients with rheumatoid arthritis. An endoscopic assessment.
Morris AD; Holt SD; Silvoso GR; Hewitt J; Tatum W; Grandione J; Butt JH; Ivey KJ
Scand J Gastroenterol Suppl; 1981; 67():131-5. PubMed ID: 6941392
[TBL] [Abstract][Full Text] [Related]
14. Double-blind comparison of lansoprazole, ranitidine, and placebo in the treatment of acute duodenal ulcer. Lansoprazole Study Group.
Lanza F; Goff J; Scowcroft C; Jennings D; Greski-Rose P
Am J Gastroenterol; 1994 Aug; 89(8):1191-200. PubMed ID: 8053433
[TBL] [Abstract][Full Text] [Related]
15. [Ranitidine in the therapy and prevention of NSAR-induced (non-steroidal anti-rheumatic agents) gastroduodenal lesions in patients with rheumatism].
Simon B; Bergdolt H; Dammann H; Müller P
Z Gastroenterol; 1991 May; 29(5):217-21. PubMed ID: 1950028
[TBL] [Abstract][Full Text] [Related]
16. Effect of ranitidine on the content of glyceroglucolipids in gastric secretion of patients with gastric and duodenal ulcer.
Sarosiek J; Slomiany BL; Slomiany A; Gabryelewicz A
Scand J Gastroenterol; 1984 Jul; 19(5):650-4. PubMed ID: 6089304
[TBL] [Abstract][Full Text] [Related]
17. [Course of histological lesions of the gastric mucosa after eradication of H. pylori in patients with duodenal ulcer. Initial study and 6-month follow-up].
Gisbert JP; Boixeda D; Alvarez Baleriola I; Redondo C; De Rafael L; Martín de Argila C; Hernández Ranz F
Rev Esp Enferm Dig; 1995 Apr; 87(4):281-7. PubMed ID: 7794634
[TBL] [Abstract][Full Text] [Related]
18. Ranitidine protects against gastroduodenal mucosal damage associated with chronic aspirin therapy.
Berkowitz JM; Rogenes PR; Sharp JT; Warner CW
Arch Intern Med; 1987 Dec; 147(12):2137-9. PubMed ID: 3689065
[TBL] [Abstract][Full Text] [Related]
19. [High-dose ranitidine protects stomach and duodenum completely against piroxicam. An endoscopic double-blind pilot study].
Müller P; Leucht U; Simon B
Z Gastroenterol; 1992 Dec; 30(12):851-3. PubMed ID: 1481550
[TBL] [Abstract][Full Text] [Related]
20. A clinical approach to management of patients with non-steroidal anti-inflammatory gastropathy.
Yeomans ND
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S89-92. PubMed ID: 10379475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
